-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Upgrades Inovio Pharmaceuticals to Buy, Announces $5 Price Target

Benzinga·11/02/2026 11:34:46
语音播报
HC Wainwright & Co. analyst Raghuram Selvaraju upgrades Inovio Pharmaceuticals (NASDAQ:INO) from Neutral to Buy and announces $5 price target.